Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
Superinvestors holding SUPN, Q2 2026
No superinvestor reported holding SUPN in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SUPN each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−11.9%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+9.0%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−13.2%)
Q3 2022
1 superinvestor holding at quarter end
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−90.5%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−26.7%)
Q2 2021
1 superinvestor holding at quarter end